Open-mkt buys · 90d
$12.00M
6 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$12.00M
Insiders on file
38
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director, 10% Owner | 29 | $46.99M | $34.39M | 2026-10-26 |
| Woods Keith | Chief Operating Officer | 8 | $0 | $1.22M | 2026-09-24 |
| Hallal David | Director | 20 | $0 | $3.97M | 2026-09-21 |
| Peng Katie | Director | 18 | $0 | $502.0K | 2026-07-01 |
| Reed Joshua | Director | 13 | $0 | $324.5K | 2026-07-01 |
| FLIER JEFFREY S. | Director | 27 | $0 | $2.21M | 2026-07-01 |
| Burow Kristina | Director, 10% Owner | 36 | $0 | $324.5K | 2026-07-01 |
| Gilman Michael | Director | 31 | $0 | $870.2K | 2026-07-01 |
| Brudnick Richard | Director | 9 | $0 | $180.5K | 2026-06-04 |
| Vaishnaw Akshay | President of R&D | 16 | $0 | $1.68M | 2026-04-16 |
| Sinha Vikas | Chief Financial Officer | 6 | $0 | $1.23M | 2026-04-16 |
| Qatanani Mo | SVP AND HEAD OF RESEARCH | 63 | $0 | $13.37M | 2026-02-23 |
| Parlavecchio Caryn | Chief Human Resources Officer | 23 | $0 | $1.63M | 2026-02-17 |
| Ho Junlin | General Counsel | 24 | $0 | $1.82M | 2026-02-17 |
| Marantz Jing L. | Chief Medical Officer | 26 | $0 | $4.06M | 2026-02-17 |
| Siren, L.L.C. | 10% Owner | 2 | $0 | $0 | 2025-12-11 |
| Sacco Tracey | Chief Commercial Officer | 17 | $0 | $1.32M | 2025-04-25 |
| Moore Erin | SVP, Finance | 7 | $0 | $449.2K | 2025-03-24 |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | 10 | $0 | $1.85M | 2025-03-10 |
| Myles Edward H | Director | 63 | $0 | $16.81M | 2025-03-10 |
| Invus Global Management, LLC | 10% Owner | 1 | $0 | $66.64M | 2024-12-10 |
| Invus Public Equities Advisors, LLC | 10% Owner | 7 | $759.6K | $15.76M | 2024-11-25 |
| Nashat Amir | Director, 10% Owner | 73 | $9.34M | $0 | 2024-05-09 |
| Samsara BioCapital GP, LLC | 10% Owner | 1 | $15.00M | $0 | 2023-10-16 |
| Wittouck Amaury | 10% Owner | 2 | $15.09M | $0 | 2023-10-12 |
| Artal International Management S.A. | 10% Owner | 1 | $202.9K | $0 | 2023-04-28 |
| Artal Group S.A. | 10% Owner | 5 | $6.76M | $10.4K | 2023-01-09 |
| Stichting Administratiekantoor Westend | 10% Owner | 1 | $1.05M | $0 | 2022-10-25 |
| Carven Gregory John | Head of Research | 28 | $0 | $4.57M | 2022-06-16 |
| Mahanthappa Nagesh K. | President and CEO | 7 | $0 | $0 | 2022-06-16 |
| CHYUNG YUNG H. | Chief Medical Officer | 7 | $0 | $0 | 2022-02-14 |
| Kingsley Stuart A | President and CEO | 4 | $0 | $0 | 2021-02-01 |
| BUCKLER ALAN J. | Chief Scientific Officer | 3 | $0 | $0 | 2020-02-06 |
| SPRINGER TIMOTHY A | Director, 10% Owner | 16 | $1000.0K | $0 | 2019-12-10 |
| CHICKO RHONDA M. | Chief Financial Officer | 2 | $0 | $0 | 2019-01-31 |
| ARCH Venture Fund VIII, L.P. | 10% Owner | 10 | $0 | $0 | 2018-05-29 |
| Polaris Venture Partners VI, L.P. | 10% Owner | 26 | $2.00M | $0 | 2018-05-29 |
| Ezickson Elan | COO & Head of Corp.Development | 1 | $0 | $0 | 2018-05-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director | P Buy | 2026-10-26 | 2026-10-27 | 97,982 | $41.59 | $4.08M | 723,020 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2026-10-26 | 2026-10-27 | 48,988 | $41.59 | $2.04M | 6,380,517 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2026-10-23 | 2026-10-27 | 1,000 | $41.82 | $41.8K | 625,038 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2026-10-23 | 2026-10-27 | 500 | $41.82 | $20.9K | 6,331,529 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2026-10-23 | 2026-10-27 | 94,000 | $41.31 | $3.88M | 624,038 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2026-10-23 | 2026-10-27 | 47,000 | $41.31 | $1.94M | 6,331,029 | SEC↗ |
| Woods Keith | Chief Operating Officer | G Gift | 2026-09-24 | 2026-09-25 | 48,034 | — | $0 | 572,021 | SEC↗ |
| Woods Keith | Chief Operating Officer | G Gift | 2026-09-24 | 2026-09-25 | 48,034 | — | $0 | 572,021 | SEC↗ |
| Hallal David | Chief Executive Officer | G Gift | 2026-09-21 | 2026-09-23 | 36,652 | — | $0 | 1,602,382 | SEC↗ |
| Hallal David | Chief Executive Officer, Dir | G Gift | 2026-09-21 | 2026-09-23 | 36,652 | — | $0 | 1,602,382 | SEC↗ |
| Peng Katie | Director | S Sale | 2026-07-01 | 2026-07-06 | 2,437 | $54.25 | $132.2K | 34,322 | SEC↗ |
| Peng Katie | Director | S Sale | 2026-07-01 | 2026-07-06 | 21 | $54.96 | $1.2K | 34,301 | SEC↗ |
| Peng Katie | Director | S Sale | 2026-07-01 | 2026-07-06 | 2,988 | $53.56 | $160.0K | 36,759 | SEC↗ |
| Reed Joshua | Director | S Sale | 2026-07-01 | 2026-07-06 | 2,105 | $53.50 | $112.6K | 20,466 | SEC↗ |
| Reed Joshua | Director | S Sale | 2026-07-01 | 2026-07-06 | 948 | $54.28 | $51.5K | 19,518 | SEC↗ |
| Burow Kristina | Director | S Sale | 2026-07-01 | 2026-07-06 | 948 | $54.28 | $51.5K | 114,657 | SEC↗ |
| Burow Kristina | Director | S Sale | 2026-07-01 | 2026-07-06 | 2,105 | $53.49 | $112.6K | 115,605 | SEC↗ |
| Gilman Michael | Director | S Sale | 2026-07-01 | 2026-07-06 | 1,155 | $54.23 | $62.6K | 59,554 | SEC↗ |
| Gilman Michael | Director | S Sale | 2026-07-01 | 2026-07-06 | 1,346 | $53.54 | $72.1K | 60,709 | SEC↗ |
| Gilman Michael | Director | S Sale | 2026-07-01 | 2026-07-06 | 43 | $54.81 | $2.4K | 59,511 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2026-07-01 | 2026-07-06 | 1,470 | $54.24 | $79.7K | 27,871 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2026-07-01 | 2026-07-06 | 15 | $54.88 | $823 | 27,856 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2026-07-01 | 2026-07-06 | 1,568 | $53.53 | $83.9K | 29,341 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| Peng Katie | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| Gilman Michael | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| Burow Kristina | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| Brudnick Richard | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| Reed Joshua | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| FLIER JEFFREY S. | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 27,971 | SEC↗ |
| Peng Katie | Director | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 39,747 | SEC↗ |
| Gilman Michael | Director | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 62,055 | SEC↗ |
| Burow Kristina | Director | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 117,710 | SEC↗ |
| Brudnick Richard | Director | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 21,896 | SEC↗ |
| Reed Joshua | Director | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 22,571 | SEC↗ |
| FLIER JEFFREY S. | Director | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 30,909 | SEC↗ |
| Burow Kristina | Director | M Exercise deriv | 2026-04-23 | 2026-04-24 | 7,800 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | M Exercise deriv | 2026-04-23 | 2026-04-24 | 28,000 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | M Exercise deriv | 2026-04-23 | 2026-04-24 | 36,000 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | M Exercise deriv | 2026-04-23 | 2026-04-24 | 18,000 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | M Exercise | 2026-04-23 | 2026-04-24 | 28,000 | $4.75 | $133.0K | 56,871 | SEC↗ |
| Burow Kristina | Director | M Exercise | 2026-04-23 | 2026-04-24 | 7,800 | $26.78 | $208.9K | 28,871 | SEC↗ |
| Burow Kristina | Director | M Exercise | 2026-04-23 | 2026-04-24 | 36,000 | $9.11 | $328.0K | 92,871 | SEC↗ |
| Burow Kristina | Director | M Exercise | 2026-04-23 | 2026-04-24 | 18,000 | $8.36 | $150.5K | 110,871 | SEC↗ |
| Hallal David | Chief Executive Officer | S Sale | 2026-04-16 | 2026-04-20 | 30,615 | $49.57 | $1.52M | 1,639,034 | SEC↗ |
| Sinha Vikas | Chief Financial Officer | S Sale | 2026-04-16 | 2026-04-20 | 10,410 | $49.57 | $516.0K | 619,856 | SEC↗ |
| Vaishnaw Akshay | President of R&D | S Sale | 2026-04-16 | 2026-04-20 | 12,246 | $49.57 | $607.0K | 630,542 | SEC↗ |
| Woods Keith | Chief Operating Officer | S Sale | 2026-04-16 | 2026-04-20 | 10,220 | $49.57 | $506.6K | 620,055 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2026-02-23 | 2026-02-25 | 857 | $47.86 | $41.0K | 98,645 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2026-02-23 | 2026-02-25 | 200 | $48.48 | $9.7K | 98,445 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2026-02-23 | 2026-02-25 | 7,427 | $46.94 | $348.6K | 99,502 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2026-02-17 | 2026-02-19 | 7,989 | $46.53 | $371.7K | 106,929 | SEC↗ |
| Parlavecchio Caryn | CHRO | S Sale | 2026-02-17 | 2026-02-19 | 9,035 | $46.53 | $420.4K | 169,087 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | S Sale | 2026-02-17 | 2026-02-19 | 9,580 | $46.53 | $445.8K | 241,545 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2026-02-17 | 2026-02-19 | 4,157 | $46.53 | $193.4K | 126,012 | SEC↗ |
| Woods Keith | Chief Operating Officer | A Award | 2026-02-09 | 2026-02-11 | 47,021 | — | $0 | 630,275 | SEC↗ |
| Hallal David | Chief Executive Officer | A Award | 2026-02-09 | 2026-02-11 | 128,004 | — | $0 | 1,669,649 | SEC↗ |
| Ho Junlin | General Counsel | A Award | 2026-02-09 | 2026-02-11 | 36,572 | — | $0 | 251,125 | SEC↗ |
| Marantz Jing L. | Chief Medical Officer | A Award | 2026-02-09 | 2026-02-11 | 34,482 | — | $0 | 130,169 | SEC↗ |
| Parlavecchio Caryn | Chief Human Resources Office | A Award | 2026-02-09 | 2026-02-11 | 29,258 | — | $0 | 178,122 | SEC↗ |
| Qatanani Mo | Chief Scientific Officer | A Award | 2026-02-09 | 2026-02-11 | 29,258 | — | $0 | 114,918 | SEC↗ |
| Sinha Vikas | Chief Financial Officer | A Award | 2026-02-09 | 2026-02-11 | 47,021 | — | $0 | 630,266 | SEC↗ |
| Vaishnaw Akshay | President of R&D | A Award | 2026-02-09 | 2026-02-11 | 47,021 | — | $0 | 642,788 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2026-01-22 | 2026-01-23 | 12,779 | $46.85 | $598.7K | 85,660 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2026-01-22 | 2026-01-23 | 2,119 | $45.87 | $97.2K | 98,439 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | S Sale | 2026-01-16 | 2026-01-21 | 8,016 | $44.48 | $356.6K | 214,553 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2026-01-16 | 2026-01-21 | 5,798 | $44.48 | $257.9K | 95,687 | SEC↗ |
| Parlavecchio Caryn | CHRO | S Sale | 2026-01-16 | 2026-01-21 | 6,600 | $44.48 | $293.6K | 148,864 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2026-01-16 | 2026-01-21 | 8,406 | $44.48 | $373.9K | 100,558 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2026-01-14 | 2026-01-16 | 321 | — | $0 | 961 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2026-01-14 | 2026-01-16 | 2,813 | — | $0 | 11,250 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2026-01-14 | 2026-01-16 | 5,893 | — | $0 | 47,143 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2026-01-14 | 2026-01-16 | 2,678 | — | $0 | 32,142 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2026-01-14 | 2026-01-16 | 1,407 | — | $0 | 0 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2026-01-14 | 2026-01-16 | 321 | $7.62 | $2.4K | 110,692 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2026-01-14 | 2026-01-16 | 2,813 | $10.00 | $28.1K | 113,505 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2026-01-14 | 2026-01-16 | 5,893 | $15.75 | $92.8K | 119,398 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2026-01-14 | 2026-01-16 | 1,407 | $18.08 | $25.4K | 110,371 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2026-01-14 | 2026-01-16 | 2,678 | $35.15 | $94.1K | 122,076 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2026-01-14 | 2026-01-16 | 13,112 | $45.20 | $592.7K | 108,964 | SEC↗ |
| Hallal David | Chief Executive Officer | S Sale | 2026-01-13 | 2026-01-15 | 57,450 | $42.70 | $2.45M | 1,541,645 | SEC↗ |
| Vaishnaw Akshay | President of R&D | S Sale | 2026-01-13 | 2026-01-15 | 20,438 | $42.70 | $872.7K | 595,767 | SEC↗ |
| Woods Keith | Chief Operating Officer | S Sale | 2026-01-13 | 2026-01-15 | 16,746 | $42.70 | $715.1K | 583,254 | SEC↗ |
| Sinha Vikas | Chief Financial Officer | S Sale | 2026-01-13 | 2026-01-15 | 16,755 | $42.70 | $715.4K | 583,245 | SEC↗ |
| Peng Katie | Director | S Sale | 2025-12-16 | 2025-12-18 | 280 | $44.63 | $12.5K | 32,908 | SEC↗ |
| Peng Katie | Director | S Sale | 2025-12-16 | 2025-12-18 | 726 | $43.88 | $31.9K | 33,188 | SEC↗ |
| AKKARAJU SRINIVAS | Director | X Exercise deriv | 2025-12-12 | 2025-12-16 | 1,064,804 | — | $0 | 0 | SEC↗ |
| AKKARAJU SRINIVAS | Director | X Exercise | 2025-12-12 | 2025-12-16 | 1,064,804 | $7.35 | $7.83M | 6,367,614 | SEC↗ |
| Siren, L.L.C. | 10% Owner | X Exercise deriv | 2025-12-11 | 2026-02-06 | 1,575,008 | — | $0 | 0 | SEC↗ |
| Siren, L.L.C. | 10% Owner | X Exercise | 2025-12-11 | 2026-02-06 | 1,575,008 | $7.35 | $11.58M | 10,825,013 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-12-04 | 2025-12-05 | 21,093 | — | $0 | 1,407 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-12-04 | 2025-12-05 | 5,607 | — | $0 | 0 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-12-04 | 2025-12-05 | 1,281 | — | $0 | 1,282 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-12-04 | 2025-12-05 | 11,250 | — | $0 | 14,063 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-12-04 | 2025-12-05 | 23,571 | — | $0 | 53,036 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-12-04 | 2025-12-05 | 8,035 | — | $0 | 34,820 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-12-04 | 2025-12-05 | 65,625 | — | $0 | 4,375 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-12-04 | 2025-12-05 | 23,571 | $15.75 | $371.2K | 237,391 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-12-04 | 2025-12-05 | 65,625 | $26.05 | $1.71M | 174,589 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-12-04 | 2025-12-05 | 136,462 | $45.21 | $6.17M | 108,964 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-12-04 | 2025-12-05 | 8,035 | $35.15 | $282.4K | 245,426 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-12-04 | 2025-12-05 | 11,250 | $10.00 | $112.5K | 213,820 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-12-04 | 2025-12-05 | 1,281 | $7.62 | $9.8K | 202,570 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-12-04 | 2025-12-05 | 5,607 | $4.86 | $27.3K | 201,289 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-12-04 | 2025-12-05 | 21,093 | $18.08 | $381.4K | 195,682 | SEC↗ |
| Hallal David | Chief Executive Officer | G Gift | 2025-10-08 | 2025-10-09 | 205,000 | — | $0 | 1,599,095 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-07 | 2025-12-16 | 12,400 | $40.18 | $498.2K | 525,635 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-07 | 2025-12-16 | 12,796 | $39.31 | $503.0K | 513,235 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-07 | 2025-12-16 | 4,403 | $40.97 | $180.4K | 530,038 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-06 | 2025-10-07 | 80,863 | $38.68 | $3.13M | 486,691 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-06 | 2025-10-07 | 13,748 | $39.52 | $543.3K | 500,439 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-06 | 2025-10-07 | 18,414 | $37.89 | $697.7K | 405,828 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-03 | 2025-10-07 | 11,011 | $35.61 | $392.1K | 11,011 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-03 | 2025-10-07 | 56,703 | $36.74 | $2.08M | 67,714 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2025-10-03 | 2025-10-07 | 319,700 | $37.42 | $11.96M | 387,414 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-09-22 | 2025-09-24 | 3,353 | $30.67 | $102.8K | 108,964 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-09-16 | 2025-09-17 | 3,178 | $33.52 | $106.5K | 112,317 | SEC↗ |
| Peng Katie | Director | S Sale | 2025-09-16 | 2025-09-17 | 930 | $32.48 | $30.2K | 33,990 | SEC↗ |
| Peng Katie | Director | S Sale | 2025-09-16 | 2025-09-17 | 76 | $33.20 | $2.5K | 33,914 | SEC↗ |
| Parlavecchio Caryn | CHRO | S Sale | 2025-08-18 | 2025-08-19 | 2,178 | $31.17 | $67.9K | 155,464 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2025-07-16 | 2025-07-18 | 11,136 | $40.02 | $445.7K | 0 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-07-08 | 2025-07-10 | 24,066 | $34.44 | $828.8K | 115,495 | SEC↗ |
| FLIER JEFFREY S. | Director | M Exercise deriv | 2025-06-23 | 2025-06-25 | 20,316 | — | $0 | 0 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2025-06-23 | 2025-06-25 | 2,766 | $32.74 | $90.6K | 24,070 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2025-06-23 | 2025-06-25 | 17,550 | $32.16 | $564.4K | 26,836 | SEC↗ |
| FLIER JEFFREY S. | Director | M Exercise | 2025-06-23 | 2025-06-25 | 20,316 | $21.62 | $439.2K | 44,386 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2025-06-23 | 2025-06-25 | 11,136 | $33.21 | $369.8K | 11,136 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | S Sale | 2025-06-16 | 2025-06-17 | 7,442 | $32.00 | $238.1K | 222,569 | SEC↗ |
| Parlavecchio Caryn | CHRO | S Sale | 2025-06-16 | 2025-06-17 | 6,186 | $32.00 | $198.0K | 157,642 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-06-16 | 2025-06-17 | 3,668 | $32.00 | $117.4K | 139,561 | SEC↗ |
| Peng Katie | Director | S Sale | 2025-06-16 | 2025-06-17 | 2,977 | $31.96 | $95.1K | 34,974 | SEC↗ |
| Peng Katie | Director | S Sale | 2025-06-16 | 2025-06-17 | 54 | $32.53 | $1.8K | 34,920 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | A Award deriv | 2025-06-09 | 2025-06-11 | 11,429 | — | $0 | 11,429 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | A Award | 2025-06-09 | 2025-06-11 | 8,571 | — | $0 | 230,011 | SEC↗ |
| Vaishnaw Akshay | President of R&D | S Sale | 2025-05-29 | 2025-05-30 | 1,620 | $30.01 | $48.6K | 616,205 | SEC↗ |
| Vaishnaw Akshay | President of R&D | S Sale | 2025-05-29 | 2025-05-30 | 5,130 | $29.63 | $152.0K | 617,825 | SEC↗ |
| Reed Joshua | Director | S Sale | 2025-05-29 | 2025-05-30 | 4,900 | $29.68 | $145.4K | 16,232 | SEC↗ |
| Reed Joshua | Director | S Sale | 2025-05-29 | 2025-05-30 | 500 | $30.04 | $15.0K | 15,732 | SEC↗ |
| Brudnick Richard | Director | S Sale | 2025-05-29 | 2025-05-30 | 4,675 | $29.63 | $138.5K | 16,457 | SEC↗ |
| Brudnick Richard | Director | S Sale | 2025-05-29 | 2025-05-30 | 1,400 | $30.00 | $42.0K | 15,057 | SEC↗ |
| Gilman Michael | Director | S Sale | 2025-05-29 | 2025-05-30 | 630 | $29.22 | $18.4K | 57,961 | SEC↗ |
| Gilman Michael | Director | S Sale | 2025-05-29 | 2025-05-30 | 2,745 | $29.83 | $81.9K | 55,216 | SEC↗ |
| Burow Kristina | Director | S Sale | 2025-05-29 | 2025-05-30 | 4,400 | $29.83 | $131.3K | 21,071 | SEC↗ |
| Burow Kristina | Director | S Sale | 2025-05-29 | 2025-05-30 | 1,000 | $29.24 | $29.2K | 25,471 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2025-05-29 | 2025-05-30 | 4,975 | $29.84 | $148.5K | 24,070 | SEC↗ |
| FLIER JEFFREY S. | Director | S Sale | 2025-05-29 | 2025-05-30 | 1,100 | $29.23 | $32.2K | 29,045 | SEC↗ |
| FLIER JEFFREY S. | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| Gilman Michael | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| Peng Katie | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| Burow Kristina | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| Reed Joshua | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| Brudnick Richard | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| FLIER JEFFREY S. | Director | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 30,145 | SEC↗ |
| Gilman Michael | Director | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 58,591 | SEC↗ |
| Peng Katie | Director | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 37,951 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 21,132 | SEC↗ |
| Burow Kristina | Director | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 26,471 | SEC↗ |
| Reed Joshua | Director | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 21,132 | SEC↗ |
| Brudnick Richard | Director | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 21,132 | SEC↗ |
| Hallal David | Chief Executive Officer | A Award deriv | 2025-05-02 | 2025-05-06 | 275,167 | — | $0 | 275,167 | SEC↗ |
| Sinha Vikas | Chief Financial Officer | A Award deriv | 2025-05-02 | 2025-05-06 | 110,067 | — | $0 | 110,067 | SEC↗ |
| Vaishnaw Akshay | President of R&D | A Award deriv | 2025-05-02 | 2025-05-06 | 110,067 | — | $0 | 110,067 | SEC↗ |
| Woods Keith | Chief Operating Officer | A Award deriv | 2025-05-02 | 2025-05-06 | 110,067 | — | $0 | 110,067 | SEC↗ |
| Sinha Vikas | Chief Financial Officer | A Award | 2025-04-27 | 2025-04-29 | 500,000 | — | $0 | 600,000 | SEC↗ |
| Sinha Vikas | Chief Financial Officer | A Award | 2025-04-27 | 2025-04-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hallal David | CEO | A Award | 2025-04-27 | 2025-04-29 | 250,000 | — | $0 | 554,095 | SEC↗ |
| Hallal David | CEO | A Award | 2025-04-27 | 2025-04-29 | 1,250,000 | — | $0 | 1,804,095 | SEC↗ |
| Vaishnaw Akshay | President of R&D | A Award | 2025-04-27 | 2025-04-29 | 500,000 | — | $0 | 622,955 | SEC↗ |
| Vaishnaw Akshay | President of R&D | A Award | 2025-04-27 | 2025-04-29 | 100,000 | — | $0 | 122,955 | SEC↗ |
| Woods Keith | Chief Operating Officer | A Award | 2025-04-27 | 2025-04-29 | 500,000 | — | $0 | 600,000 | SEC↗ |
| Woods Keith | Chief Operating Officer | A Award | 2025-04-27 | 2025-04-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | M Exercise deriv | 2025-04-25 | 2025-04-29 | 5,000 | — | $0 | 185,000 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | M Exercise | 2025-04-25 | 2025-04-29 | 5,000 | $10.00 | $50.0K | 76,250 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | S Sale | 2025-04-25 | 2025-04-29 | 4,916 | $32.81 | $161.3K | 71,834 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | S Sale | 2025-04-25 | 2025-04-29 | 84 | $33.49 | $2.8K | 71,750 | SEC↗ |
| Moore Erin | Interim PFO and PAO | M Exercise deriv | 2025-03-24 | 2025-03-25 | 8,564 | — | $0 | 40,724 | SEC↗ |
| Moore Erin | Interim PFO and PAO | M Exercise deriv | 2025-03-24 | 2025-03-25 | 5,000 | — | $0 | 11,764 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | M Exercise deriv | 2025-03-24 | 2025-03-25 | 5,000 | — | $0 | 190,000 | SEC↗ |
| Moore Erin | Interim PFO and PAO | M Exercise | 2025-03-24 | 2025-03-25 | 8,564 | $13.52 | $115.8K | 96,173 | SEC↗ |
| Moore Erin | Interim PFO and PAO | M Exercise | 2025-03-24 | 2025-03-25 | 5,000 | $23.86 | $119.3K | 87,609 | SEC↗ |
| Moore Erin | Interim PFO and PAO | S Sale | 2025-03-24 | 2025-03-25 | 13,564 | $33.12 | $449.2K | 82,609 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | S Sale | 2025-03-24 | 2025-03-25 | 1,500 | $33.70 | $50.6K | 76,750 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | S Sale | 2025-03-24 | 2025-03-25 | 5,000 | $32.89 | $164.4K | 71,750 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | M Exercise | 2025-03-24 | 2025-03-25 | 5,000 | $10.00 | $50.0K | 78,250 | SEC↗ |
| Peng Katie | Director | S Sale | 2025-03-17 | 2025-03-19 | 1,006 | $34.42 | $34.6K | 30,319 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | A Award deriv | 2025-03-10 | 2025-03-12 | 37,145 | — | $0 | 37,145 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | A Award deriv | 2025-03-10 | 2025-03-12 | 42,855 | — | $0 | 42,855 | SEC↗ |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-03-10 | 2025-03-12 | 151,430 | — | $0 | 151,430 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | A Award deriv | 2025-03-10 | 2025-03-12 | 45,715 | — | $0 | 45,715 | SEC↗ |
| Parlavecchio Caryn | CHRO | A Award deriv | 2025-03-10 | 2025-03-12 | 31,430 | — | $0 | 31,430 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-03-10 | 2025-03-12 | 42,855 | — | $0 | 42,855 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise deriv | 2025-03-10 | 2025-03-12 | 17,857 | — | $0 | 53,573 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise deriv | 2025-03-10 | 2025-03-12 | 5,313 | — | $0 | 42,500 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise deriv | 2025-03-10 | 2025-03-12 | 43,122 | — | $0 | 14,378 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise deriv | 2025-03-10 | 2025-03-12 | 21,690 | — | $0 | 0 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise deriv | 2025-03-10 | 2025-03-12 | 24,915 | — | $0 | 12,462 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | A Award | 2025-03-10 | 2025-03-12 | 27,855 | — | $0 | 73,250 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | A Award | 2025-03-10 | 2025-03-12 | 32,145 | — | $0 | 221,440 | SEC↗ |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A Award | 2025-03-10 | 2025-03-12 | 113,570 | — | $0 | 425,561 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | A Award | 2025-03-10 | 2025-03-12 | 34,285 | — | $0 | 101,485 | SEC↗ |
| Parlavecchio Caryn | CHRO | A Award | 2025-03-10 | 2025-03-12 | 23,570 | — | $0 | 163,828 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | A Award | 2025-03-10 | 2025-03-12 | 32,145 | — | $0 | 143,229 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2025-03-10 | 2025-03-12 | 29,395 | $34.87 | $1.03M | 111,345 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise | 2025-03-10 | 2025-03-12 | 21,690 | $13.83 | $300.0K | 162,430 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise | 2025-03-10 | 2025-03-12 | 43,122 | $18.08 | $779.6K | 205,552 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise | 2025-03-10 | 2025-03-12 | 24,915 | $4.86 | $121.1K | 230,467 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise | 2025-03-10 | 2025-03-12 | 5,313 | $10.00 | $53.1K | 235,780 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise | 2025-03-10 | 2025-03-12 | 17,857 | $15.75 | $281.2K | 253,637 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2025-03-10 | 2025-03-12 | 112,897 | $35.82 | $4.04M | 140,740 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-02-19 | 2025-02-20 | 16,818 | — | $0 | 5,607 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-02-19 | 2025-02-20 | 2,562 | — | $0 | 2,563 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-02-19 | 2025-02-20 | 11,250 | — | $0 | 25,313 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-02-19 | 2025-02-20 | 17,678 | — | $0 | 76,607 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-02-19 | 2025-02-20 | 8,341 | $37.56 | $313.3K | 131,286 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-02-19 | 2025-02-20 | 20,202 | $37.74 | $762.4K | 111,084 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-02-19 | 2025-02-20 | 39,967 | $37.20 | $1.49M | 139,627 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-02-19 | 2025-02-20 | 17,678 | $15.75 | $278.4K | 179,594 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-02-19 | 2025-02-20 | 11,250 | $10.00 | $112.5K | 161,916 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-02-19 | 2025-02-20 | 2,562 | $7.62 | $19.5K | 150,666 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-02-19 | 2025-02-20 | 16,818 | $4.86 | $81.7K | 148,104 | SEC↗ |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | S Sale | 2025-02-18 | 2025-02-20 | 18,372 | $36.83 | $676.6K | 311,991 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | S Sale | 2025-02-18 | 2025-02-20 | 5,742 | $36.83 | $211.5K | 189,295 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2025-02-18 | 2025-02-20 | 7,809 | $36.83 | $287.6K | 140,740 | SEC↗ |
| Parlavecchio Caryn | CHRO | S Sale | 2025-02-18 | 2025-02-20 | 5,296 | $36.83 | $195.1K | 140,258 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-02-18 | 2025-02-20 | 4,135 | $36.83 | $152.3K | 131,286 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | S Sale | 2025-01-16 | 2025-01-21 | 9,039 | $44.20 | $399.5K | 195,037 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2025-01-16 | 2025-01-21 | 12,539 | $44.20 | $554.2K | 148,549 | SEC↗ |
| Parlavecchio Caryn | CHRO | S Sale | 2025-01-16 | 2025-01-21 | 6,434 | $44.20 | $284.4K | 145,554 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-01-16 | 2025-01-21 | 7,347 | $44.20 | $324.7K | 135,421 | SEC↗ |
| Sacco Tracey | Chief Commercial Officer | S Sale | 2025-01-16 | 2025-01-21 | 3,890 | $44.20 | $171.9K | 45,395 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2025-01-16 | 2025-01-21 | 5,655 | $44.20 | $250.0K | 67,200 | SEC↗ |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | S Sale | 2025-01-16 | 2025-01-21 | 22,308 | $44.20 | $986.0K | 330,363 | SEC↗ |
| Invus Global Management, LLC | 10% Owner | S Sale | 2024-12-10 | 2024-12-12 | 1,600,000 | $41.65 | $66.64M | 9,250,005 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-11-25 | 2024-11-26 | 6,375 | — | $0 | 130,000 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | M Exercise | 2024-11-25 | 2024-11-26 | 6,375 | $8.59 | $54.8K | 79,230 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-11-25 | 2024-11-26 | 1,000 | $38.04 | $38.0K | 78,230 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-11-25 | 2024-11-26 | 2,100 | $39.25 | $82.4K | 76,130 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-11-25 | 2024-11-26 | 3,075 | $39.93 | $122.8K | 73,055 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-11-25 | 2024-11-26 | 200 | $40.72 | $8.1K | 72,855 | SEC↗ |
| Invus Public Equities Advisors | 10% Owner | S Sale | 2024-11-25 | 2024-11-27 | 30,683 | $40.14 | $1.23M | 10,850,154 | SEC↗ |
| Invus Public Equities Advisors | 10% Owner | S Sale | 2024-11-25 | 2024-11-27 | 149 | $40.98 | $6.1K | 10,850,005 | SEC↗ |
| Invus Public Equities Advisors | 10% Owner | S Sale | 2024-11-25 | 2024-11-27 | 126,442 | $39.51 | $5.00M | 10,880,837 | SEC↗ |
| Invus Public Equities Advisors | 10% Owner | S Sale | 2024-11-25 | 2024-11-27 | 43,887 | $38.43 | $1.69M | 11,007,279 | SEC↗ |
| Invus Public Equities Advisors | 10% Owner | S Sale | 2024-11-25 | 2024-11-27 | 208,272 | $37.63 | $7.84M | 11,051,166 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-11-22 | 2024-11-26 | 2,145 | — | $0 | 136,375 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-11-22 | 2024-11-26 | 2,145 | $30.01 | $64.4K | 72,855 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | M Exercise | 2024-11-22 | 2024-11-26 | 2,145 | $8.59 | $18.4K | 75,000 | SEC↗ |
| Gilman Michael | Director | G Gift | 2024-11-12 | 2024-11-13 | 37,459 | — | $0 | 0 | SEC↗ |
| Gilman Michael | Director | G Gift | 2024-11-12 | 2024-11-13 | 37,459 | — | $0 | 50,959 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-11-11 | 2024-11-13 | 2,105 | — | $0 | 138,520 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-11-11 | 2024-11-13 | 2,105 | $30.00 | $63.1K | 72,855 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | M Exercise | 2024-11-11 | 2024-11-13 | 2,105 | $8.59 | $18.1K | 74,960 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise deriv | 2024-10-08 | 2024-10-10 | 37,187 | — | $0 | 47,813 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise | 2024-10-08 | 2024-10-10 | 37,187 | $10.00 | $371.9K | 198,275 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2024-10-08 | 2024-10-10 | 37,187 | $34.90 | $1.30M | 161,088 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-10-07 | 2024-10-07 | 109,375 | — | $0 | 140,625 | SEC↗ |
| Sacco Tracey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-10-07 | 2024-10-07 | 30,000 | — | $0 | 140,625 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise deriv | 2024-10-07 | 2024-10-07 | 165,810 | — | $0 | 0 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-10-07 | 2024-10-07 | 39,375 | $30.06 | $1.18M | 72,855 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-10-07 | 2024-10-07 | 2,552 | $26.22 | $66.9K | 112,230 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | M Exercise | 2024-10-07 | 2024-10-07 | 109,375 | $8.59 | $939.5K | 182,230 | SEC↗ |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | S Sale | 2024-10-07 | 2024-10-07 | 67,448 | $25.59 | $1.73M | 114,782 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2024-10-07 | 2024-10-07 | 510,000 | $30.00 | $15.30M | 5,768,609 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2024-10-07 | 2024-10-07 | 510,000 | $27.50 | $14.03M | 6,278,609 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2024-10-07 | 2024-10-07 | 155,713 | $32.50 | $5.06M | 5,612,896 | SEC↗ |
| Sacco Tracey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-10-07 | 2024-10-07 | 1,964 | $26.23 | $51.5K | 49,285 | SEC↗ |
| Sacco Tracey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-10-07 | 2024-10-07 | 28,036 | $25.58 | $717.2K | 51,249 | SEC↗ |
| Sacco Tracey | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-10-07 | 2024-10-07 | 30,000 | $10.00 | $300.0K | 79,285 | SEC↗ |
| Myles Edward H | COO & CFO | M Exercise | 2024-10-07 | 2024-10-07 | 206,240 | $13.83 | $2.85M | 367,328 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2024-10-07 | 2024-10-07 | 111,972 | $25.61 | $2.87M | 255,356 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2024-10-07 | 2024-10-07 | 25,812 | $27.27 | $703.9K | 192,338 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2024-10-07 | 2024-10-07 | 37,206 | $26.83 | $998.2K | 218,150 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2024-10-07 | 2024-10-07 | 31,250 | $29.05 | $907.8K | 161,088 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-09-16 | 2024-09-19 | 1,936 | $8.58 | $16.6K | 142,768 | SEC↗ |
| Parlavecchio Caryn | CHRO | S Sale | 2024-08-16 | 2024-08-19 | 1,451 | $9.33 | $13.5K | 151,988 | SEC↗ |
| Hallal David | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Brudnick Richard | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FLIER JEFFREY S. | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Gilman Michael | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Peng Katie | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Reed Joshua | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Vaishnaw Akshay | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Burow Kristina | Director | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Hallal David | Director | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 304,095 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 13,500 | SEC↗ |
| Brudnick Richard | Director | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 13,500 | SEC↗ |
| FLIER JEFFREY S. | Director | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 22,513 | SEC↗ |
| Gilman Michael | Director | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 13,500 | SEC↗ |
| Peng Katie | Director | A Award | 2024-06-27 | 2024-07-01 | 4,500 | — | $0 | 31,325 | SEC↗ |
| Reed Joshua | Director | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 13,500 | SEC↗ |
| Vaishnaw Akshay | Director | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 22,955 | SEC↗ |
| Burow Kristina | Director | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 18,839 | SEC↗ |
| Ho Junlin | GENERAL COUNSEL | S Sale | 2024-06-17 | 2024-06-18 | 4,695 | $8.98 | $42.2K | 204,076 | SEC↗ |
| Myles Edward H | COO & CFO | S Sale | 2024-06-17 | 2024-06-18 | 9,458 | $8.98 | $84.9K | 201,518 | SEC↗ |
| Parlavecchio Caryn | CHRO | S Sale | 2024-06-17 | 2024-06-18 | 4,305 | $8.98 | $38.7K | 153,439 | SEC↗ |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-06-17 | 2024-06-18 | 2,315 | $8.99 | $20.8K | 144,704 | SEC↗ |
| Nashat Amir | Director | J Other | 2024-05-09 | 2024-05-13 | 276 | — | $0 | 0 | SEC↗ |